Subscribe
dna-istock-518143098-ralwel--2
ralwel / iStockphoto.com
26 April 2018Asia-Pacific

Merck KGaA secures CRISPR patent in China

China’s State Intellectual Property Office (SIPO) has granted Merck KGaA a patent covering its CRISPR technology used in a genomic-integration method for eukaryotic cells.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Asia-Pacific
Merck granted its first CRISPR patent in Australia
16 June 2017   Merck has been granted its first CRISPR technology patent by the Australian Patent Office.
Americas
GSK and Merck KGaA unite in €3.7bn immunotherapy deal
6 February 2019   UK headquartered GSK has made another move in the oncology space, signing a potential €3.7 billion immunotherapy deal with Germany-based Merck KGaA.
Asia
Merck KGaA secures CRISPR patents in Japan and Singapore
27 November 2019   The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

More on this story

Asia-Pacific
Merck granted its first CRISPR patent in Australia
16 June 2017   Merck has been granted its first CRISPR technology patent by the Australian Patent Office.
Americas
GSK and Merck KGaA unite in €3.7bn immunotherapy deal
6 February 2019   UK headquartered GSK has made another move in the oncology space, signing a potential €3.7 billion immunotherapy deal with Germany-based Merck KGaA.
Asia
Merck KGaA secures CRISPR patents in Japan and Singapore
27 November 2019   The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.

More on this story

Asia-Pacific
Merck granted its first CRISPR patent in Australia
16 June 2017   Merck has been granted its first CRISPR technology patent by the Australian Patent Office.
Americas
GSK and Merck KGaA unite in €3.7bn immunotherapy deal
6 February 2019   UK headquartered GSK has made another move in the oncology space, signing a potential €3.7 billion immunotherapy deal with Germany-based Merck KGaA.
Asia
Merck KGaA secures CRISPR patents in Japan and Singapore
27 November 2019   The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent